Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population
This study used positive and negative sample panels from Nigeria to test the performance of several commercially available SARS-CoV-2 serological assays. Using these prepandemic and SARS-CoV-2-positive samples, we found much lower levels of sensitivity in four commercially available assays than most assay manufacturer reports and independent evaluations.
Keyword(s):
1979 ◽
Vol 35
(11)
◽
pp. 1428-1429
◽
1978 ◽
Vol 5
(3)
◽
pp. 143-147
◽
2015 ◽
Vol 41
(4)
◽
pp. S107-S108
Keyword(s):